Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic-guided Risk Assessment and Management of Thyroid Cancer
Mingzhao Xing
Endocrinology and Metabolism Clinics of North America (2019) Vol. 48, Iss. 1, pp. 109-124
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Current practice in patients with differentiated thyroid cancer
Martin Schlumberger, Sophie Leboulleux
Nature Reviews Endocrinology (2020) Vol. 17, Iss. 3, pp. 176-188
Closed Access | Times Cited: 253
Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-Up
R. Michael Tuttle, Ali S. Alzahrani
The Journal of Clinical Endocrinology & Metabolism (2019) Vol. 104, Iss. 9, pp. 4087-4100
Open Access | Times Cited: 130
Papillary Thyroid Cancer Prognosis: An Evolving Field
Salvatore Ulisse, Enke Baldini, Augusto Lauro, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5567-5567
Open Access | Times Cited: 84
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma
Kyeong Jin Kim, Sin Gon Kim, Jie Tan, et al.
European Journal of Cancer (2019) Vol. 124, pp. 161-169
Open Access | Times Cited: 45
Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics
Songting Shou, Ayidana Maolan, Di Zhang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples
Cihan Kaya, Princesca Dorsaint, Stephanie Mercurio, et al.
Thyroid (2020) Vol. 31, Iss. 4, pp. 589-595
Open Access | Times Cited: 28
TERT Promoter Mutations and the 8th Edition TNM Classification in Predicting the Survival of Thyroid Cancer Patients
Jun Park, Sungjoo Lee, Kyunga Kim, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 648-648
Open Access | Times Cited: 26
Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: a retrospective chart review
Jessica Hier, Galit Avior, Marc Pusztaszeri, et al.
Journal of Otolaryngology - Head and Neck Surgery (2021) Vol. 50, Iss. 1
Open Access | Times Cited: 26
Biomarkers in Thyroid Cancer: Emerging Opportunities from Non-Coding RNAs and Mitochondrial Space
Patricio Cabané T, Claudio Correa, Ignacio Bode, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6719-6719
Open Access | Times Cited: 3
US of thyroid nodules: can AI-assisted diagnostic system compete with fine needle aspiration?
Tianhan Zhou, Lei Xu, Jingjing Shi, et al.
European Radiology (2023) Vol. 34, Iss. 2, pp. 1324-1333
Closed Access | Times Cited: 8
Lactate Dehydrogenase A as a Potential New Biomarker for Thyroid Cancer
Eun Jeong Ban, Daham Kim, Jin Kyong Kim, et al.
Endocrinology and Metabolism (2021) Vol. 36, Iss. 1, pp. 96-105
Open Access | Times Cited: 20
Clinical and prognosis value of the number of metastatic lymph nodes in patients with papillary thyroid carcinoma
Ling Zhan, Hong-Fang Feng, Xizi Yu, et al.
BMC Surgery (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Dynamic risk assessment in patients with differentiated thyroid cancer
Erika Abelleira, Fernando Jerkovich
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 25, Iss. 1, pp. 79-93
Closed Access | Times Cited: 7
Molecular testing and thyroid nodule management in North America
N. Paul Ohori
Gland Surgery (2020) Vol. 9, Iss. 5, pp. 1628-1638
Open Access | Times Cited: 18
SGSM2 inhibits thyroid cancer progression by activating RAP1 and enhancing competitive RAS inhibition
Xi Su, Dong Chen, Lizhang Zhu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 10
Genetic trio of BRAF and TERT alterations and rs2853669TT in papillary thyroid cancer aggressiveness
Rengyun Liu, Guangwu Zhu, Jie Tan, et al.
JNCI Journal of the National Cancer Institute (2023) Vol. 116, Iss. 5, pp. 694-701
Closed Access | Times Cited: 6
Unmet Clinical Needs in the Treatment of Patients with Thyroid Cancer
Won Bae Kim, Min Ji Jeon, Won Gu Kim, et al.
Endocrinology and Metabolism (2020) Vol. 35, Iss. 1, pp. 14-25
Open Access | Times Cited: 14
Telomerase reverse transcriptase promoter mutations in thyroid carcinomas: implications in precision oncology—a narrative review
Xiaotian Yuan, Tiantian Liu, Dawei Xu
Annals of Translational Medicine (2020) Vol. 8, Iss. 19, pp. 1244-1244
Open Access | Times Cited: 13
Predictive Value of a Genomic Classifier in Indeterminate Thyroid Nodules Based on Nodule Size
Jared C. Dublin, Michael R. Papazian, Elçin Zan, et al.
JAMA Otolaryngology–Head & Neck Surgery (2021) Vol. 148, Iss. 1, pp. 53-53
Open Access | Times Cited: 12
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is rare, benign lesion using modified stringent diagnostic criteria: Reclassification and outcome study
David Cubero Rego, Hwajeong Lee, Anne Boguniewicz, et al.
Annals of Diagnostic Pathology (2019) Vol. 44, pp. 151439-151439
Closed Access | Times Cited: 13
Comparison of surgical strategies in the treatment of low-risk differentiated thyroid cancer
András Kiss, Balázs Szili, Bence Bakos, et al.
BMC Endocrine Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Is There a Role for Molecular Testing for Low-Risk Differentiated Thyroid Cancer? A Cost-Effectiveness Analysis
Idit Tessler, Moshe Leshno, Gilad Feinmesser, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 786-786
Open Access | Times Cited: 4
Proposal of a New Prognostic Model for Differentiated Thyroid Cancer with TERT Promoter Mutations
Jun Park, Sungjoo Lee, Jiyun Park, et al.
Cancers (2021) Vol. 13, Iss. 12, pp. 2943-2943
Open Access | Times Cited: 10
EGR1/2 Inhibits Papillary Thyroid Carcinoma Cell Growth by Suppressing the Expression of PTEN and BAX
Hao Guo, Linlei Zhang
Biochemical Genetics (2021) Vol. 59, Iss. 6, pp. 1544-1557
Closed Access | Times Cited: 9
An integrative analysis of the tumor suppressors and oncogenes from sexual dimorphism and gene expression alteration features in thyroid cancer
Yue Huang, Wang Yao-xin, Sining Liu, et al.
Cancer Biomarkers (2023) Vol. 38, Iss. 1, pp. 1-16
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top